Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | N/A | 0 | 60,160 |
| Receivables | 0 | 0 | N/A | 0 | 390 |
| Other current assets | 0 | 0 | 0 | 0 | 150 |
| TOTAL | $0 | $0 | $N/A | $0 | $60,700 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | -14,150 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 2,730 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $-11,420 |
| Total Assets | $0 | $0 | $N/A | $0 | $63,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 2,280 |
| Other current liabilities | 0 | 0 | N/A | 0 | 15,920 |
| TOTAL | $0 | $0 | $N/A | $0 | $19,190 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | N/A | 0 | 1,660 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $13,820 |
| Total Liabilities | $0 | $0 | $N/A | $0 | $50,680 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | N/A | 0 | 6,140 |
| Retained earnings | 0 | 0 | N/A | 0 | -128,780 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 105,540 |
| TOTAL | $0 | $0 | $N/A | $0 | $12,620 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $63,300 |